Oxford Nanopore has developed a new generation of nanopore-based sensing technology for faster, information-rich, accessible and affordable molecular analysis. The technology is used to understand and characterise the biology of humans, animals, plants, bacteria, viruses, and diseases such as cancer. By enabling biological insights, we strive to improve life on Earth and beyond.
Director, Strategic Planning
Location: Oxford (Hybrid)
The Role:
Oxford Nanopore is seeking a highly motivated and analytically sharp Director of Strategic Planning to join its Corporate team. This role sits at the centre of ONT’s enterprise planning system, shaping how the business aligns around its strategic goals and drives execution at scale.
You will be responsible for leading the rhythm of strategic planning, facilitating cross-functional alignment and ensuring the company’s most important priorities are clearly defined, owned, and tracked. You’ll enablie high-quality decisions, trade-offs, and coordination across functions.
This role will focus on about building the infrastructure of strategic focus at one of the most innovative companies in genomics. The ideal candidate will have a strong analytical and systems mindset, thrive in ambiguity, and be excited to help ONT scale its impact through structured, insight-led planning.
Key Responsibilities:
Strategic Planning and Alignment
Program and Initiative Governance
Strategic Insight & Executive Support
Candidate Profile:
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#li-rs1
#li-hybrid
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
